![]() |
|
|
|||||||
|
|
LinkBack | Thread Tools | Display Modes |
|
|||
|
Clarient, Inc., a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that data from a new study suggest that the Clarient Insight Dx Pulmotax assay may effectively predict which lung cancer patients will respond favorably to chemotherapy. The study, titled "TLE3 expression is predictive of response to chemotherapy in NSCLC ...
|
| Thread Tools | |
| Display Modes | |
|
|
|
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| DiaTech Oncology MiCK Assay Can Predict Best Chemotherapy For Endometrial Cancer Pati | cancerfr | Ovarian Cancer | 0 | 07-13-2010 05:16 PM |
| MiCK assay effective in predicting best chemotherapy response for Endometrial Cancer | cancerfr | Endometrial Cancer | 0 | 07-12-2010 01:40 PM |
| DiaTech Oncology MiCK Assay Can Predict Best Chemotherapy for Endometrial Cancer Pati | cancerfr | Endometrial Cancer | 0 | 07-12-2010 11:53 AM |
| DiaTech Oncology MiCK Chemotherapy Induced Apoptosis Assay Shows Increased Response a | cancerfr | Ovarian Cancer | 0 | 05-26-2010 05:14 PM |